Commit Biologics
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$22.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Commit Biologics is a biotechnology company that develops a novel immunotherapy platform, BiCE™, to treat cancer and autoimmune diseases by activating the complement system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Commit Biologics Comparables
Compare Commit Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affimed N.V. | 69% | |
| NovelMed Therapeutics | 68% | |
| Kira Pharmaceuticals | 65% |
Commit Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 | ||||
| Seed | May 9, 2024 |
Key People
Founding team and executive leadership
Commit Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korys | Seed |
| Novo Holdings | Seed |
| Bioqube Ventures | Seed |
| BioInnovation Institute | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 53% MoM.
- Mar 16, 2026
Intention to advance complement-powered immune engagers into clinical trials.
Commit Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Commit Biologics's valuation, stock price, and market status.
Is Commit Biologics a public or private company?
Commit Biologics is a private company.
What is the current stock price of Commit Biologics?
Commit Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Commit Biologics worth (valuation)?
Valuation information for Commit Biologics is not publicly available.
Can I buy Commit Biologics stock?
Commit Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Commit Biologics's last funding round?
Commit Biologics's most recent funding round was Seed on January 28, 2025.
Who are the main investors in Commit Biologics?
Key investors in Commit Biologics include Korys, Novo Holdings, Bioqube Ventures.
Will Commit Biologics IPO soon?
No public IPO plans have been announced for Commit Biologics.
How can I track Commit Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Commit Biologics's secondary market activity and sign up for updates.